The Laboratory Approach to Inherited and Acquired Coagulation Factor Deficiencies

被引:12
作者
Wagenman, Benjamin L. [1 ,4 ]
Townsend, Kelly T. [1 ]
Mathew, Prasad [2 ,3 ]
Crookston, Kendall P. [1 ,4 ]
机构
[1] Univ New Mexico, Dept Pathol, TriCore Reference Labs, Albuquerque, NM 87102 USA
[2] Univ New Mexico, Dept Pediat, Albuquerque, NM 87106 USA
[3] Univ New Mexico, Ted R Montoya Hemophilia Program, Albuquerque, NM 87106 USA
[4] United Blood Serv New Mexico, Albuquerque, NM 87102 USA
关键词
Hemophilia; Coagulation factor deficiency; Hypoprothrombinemia; Hemostasis; Prothrombin time; Activated partial thromboplastin time; Pre-analytical variables; Bleeding; Coagulation factor inhibitors; FACTOR-XI DEFICIENCY; BLEEDING DISORDERS; HEMOPHILIA-A; FACTOR-V; MANAGEMENT; DIAGNOSIS; INHIBITORS; HEMOSTASIS;
D O I
10.1016/j.cll.2009.04.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Besides the long-recognized hemophilias, there are many other factor deficiencies. Some also are inherited, but others are acquired because of both immune and nonimmune etiologies. Understanding the optimal laboratory approach to evaluating factor deficiency will aid physicians and laboratory scientists in obtaining a prompt diagnosis and in avoiding pitfalls in coagulation testing.
引用
收藏
页码:229 / +
页数:25
相关论文
共 33 条
  • [1] ANDRE S, 2009, CLIN REV AL IN PRESS
  • [2] Inherited defects of coagulation factor V: the hemorrhagic side
    Asselta, R
    Tenchini, ML
    Duga, S
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 26 - 34
  • [3] BANNINGER H, 1993, BRIT J HAEMATOL, V85, P528
  • [4] Current management of acquired factor VIII inhibitors
    Barnett, Brian
    Kruse-Jarres, Rebecca
    Leissinger, Cindy A.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2008, 15 (05) : 451 - 455
  • [5] Diagnosis and treatment of inherited factor X deficiency
    Brown, D. L.
    Kouides, P. A.
    [J]. HAEMOPHILIA, 2008, 14 (06) : 1176 - 1182
  • [6] Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy
    Choufani, EB
    Sanchorawala, V
    Ernst, T
    Quillen, K
    Skinner, M
    Wright, DG
    Seldin, DC
    [J]. BLOOD, 2001, 97 (06) : 1885 - 1887
  • [7] Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome
    Collins, P.
    Budde, U.
    Rand, J. H.
    Federici, A. B.
    Kessler, C. M.
    [J]. HAEMOPHILIA, 2008, 14 : 49 - 55
  • [8] Preanalytical and Postanalytical Variables: The Leading Causes of Diagnostic Error in Hemostasis?
    Favaloro, Emmanuel J.
    Lippi, Giuseppe
    Adcock, Dorothy M.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (07) : 612 - 634
  • [9] Flanders MM, 2005, CLIN CHEM, V51, P1738, DOI 10.1373/clinchem.2005.050211
  • [10] Acquired coagulation inhibitor-associated bleeding disorders: An update
    Franchini, M
    Veneri, D
    [J]. HEMATOLOGY, 2005, 10 (06) : 443 - 449